Your browser doesn't support javascript.
loading
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.
Jardine, Meg J; Zhou, Zien; Mahaffey, Kenneth W; Oshima, Megumi; Agarwal, Rajiv; Bakris, George; Bajaj, Harpreet S; Bull, Scott; Cannon, Christopher P; Charytan, David M; de Zeeuw, Dick; Di Tanna, Gian Luca; Greene, Tom; Heerspink, Hiddo J L; Levin, Adeera; Neal, Bruce; Pollock, Carol; Qiu, Rose; Sun, Tao; Wheeler, David C; Zhang, Hong; Zinman, Bernard; Rosenthal, Norman; Perkovic, Vlado.
Afiliação
  • Jardine MJ; The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia mjardine@georgeinstitute.org.au.
  • Zhou Z; Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Mahaffey KW; The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Oshima M; Department of Radiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Agarwal R; Department of Medicine, Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, California.
  • Bakris G; The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Bajaj HS; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.
  • Bull S; Indiana University School of Medicine and Veterans Affairs Medical Center, Indianapolis, Indiana.
  • Cannon CP; Department of Medicine, University of Chicago Medicine, Chicago, Illinois.
  • Charytan DM; LMC Healthcare, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • de Zeeuw D; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Di Tanna GL; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Greene T; Baim Institute for Clinical Research, Boston, Massachusetts.
  • Heerspink HJL; Baim Institute for Clinical Research, Boston, Massachusetts.
  • Levin A; Nephrology Division, New York University Langone Medical Center, New York University School of Medicine, New York, New York.
  • Neal B; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Pollock C; The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Qiu R; Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
  • Sun T; The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Wheeler DC; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Zhang H; Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Zinman B; The George Institute for Global Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Rosenthal N; The Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Perkovic V; Imperial College London, London, United Kingdom.
J Am Soc Nephrol ; 31(5): 1128-1139, 2020 05.
Article em En | MEDLINE | ID: mdl-32354987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Canagliflozina / Inibidores do Transportador 2 de Sódio-Glicose / Rim Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Canagliflozina / Inibidores do Transportador 2 de Sódio-Glicose / Rim Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article